Kidney Disease
177
26
31
108
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
30 trials with published results (17%)
Research Maturity
108 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
10 terminated out of 177 trials
91.5%
+5.0% vs benchmark
24%
42 trials in Phase 3/4
28%
30 of 108 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 108 completed trials
Clinical Trials (177)
The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasis Patients.
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
Immune System Related Kidney Disease
Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health
Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation
MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.
Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
The Adaptive Platform Trial for Kidney Disease
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
Clinical Information System Impact on Hospitalized Patients With Chronic Disease
RaDIANT Health Systems Intervention
A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive
Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Effects of an Exercise and Diet Program on Biochemistry and Body Composition in Patients With CKD in G1 and G2 Stages